Drug intelligence / Profile preview

Huoxue Xiaotong Ding

Development stage: Unknown
Lead developer: Henan Lingrui Pharmaceutical
Modality: Small Molecules
Administration: Topical

Overview

Huoxue Xiaotong Ding is a traditional Chinese medicine (TCM) topical tincture developed and marketed by Henan Lingrui Pharmaceutical. It is specifically formulated to promote blood circulation and alleviate pain associated with musculoskeletal conditions. The product is applied externally to the affected area to provide local analgesic effects. As a traditional formulation, it utilizes a blend of herbal extracts to achieve its therapeutic goals, and it is currently approved and commercially available in China. It is categorized within Lingrui's plaster and topical medication division.

Brand names: Huoxue Xiaotong Ding活血消痛酊
Other names: Blood-activating Pain-relief Tincture

Beyond the preview

Go deeper on Huoxue Xiaotong Ding.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Huoxue Xiaotong Ding.

Explore the full profile